Blood Coagulation Tests Concept

subject area of

• 10 Anticoagulant therapy in venous thromboembolism  Academic Article
• 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants  Academic Article
• A Comparison of Lyophilized Artificially Depleted Plasmas and Lyophilized Plasmas From Patients Receiving Warfarin in Correcting for Coagulometer Effects on International Normalized Ratios  Academic Article
• A New Short Infusion Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Venous Thromboembolic Disease  Academic Article
• A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time  Academic Article
• A Step Change in Oral Anticoagulation: Lack of Coagulation Monitoring with Ximelagatran  Academic Article
• A cohort study of coagulation parameters and the use of blood products in surgery of the thoracic and thoracoabdominal aorta  Academic Article
• A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin–antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen  Academic Article
• A complete deletion of the factor IX gene and new TaqI variant in a hemophilia B kindred  Academic Article
• A comprehensive study of ovine haemostasis to assess suitability to model human coagulation  Academic Article
• A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism  Academic Article
• A personalized limited sampling approach to better estimate terminal half‐life of FVIII concentrates  Academic Article
• A prospective study investigating the mechanism of thrombocytopenia in preeclampsia.  Academic Article
• Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy  Academic Article
• Activated protein C resistance, factor V Leiden and peripheral vascular disease.  Academic Article
• Acute management of bleeding in patients on novel oral anticoagulants  Academic Article
• An Assessment of the State of Current Practice in Coagulation Laboratories  Academic Article
• Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls  Academic Article
• Anticoagulants in Venous Thromboembolism  Academic Article
• Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism  Academic Article
• Antithrombin III-Amiens: A new family with an Arg47 → cys inherited variant of antithrombin iii with impaired heparin cofactor activity  Academic Article
• Antithrombotic Properties of Heparin in a Neonatal Piglet Model of Thrombin-Induced Thrombosis  Academic Article
• Antithrombotic Therapy in Neonates and Children  Academic Article
• Approaches to the measurement of the response to Factor VIII concentrate infusion  Academic Article
• Are laboratories following published recommendations for lupus anticoagulant testing?  Academic Article
• Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia  Academic Article
• Assays for Measuring Rivaroxaban: Their Suitability and Limitations  Academic Article
• Assembly and evaluation of an inventory of guidelines that are available to support clinical hematology laboratory practice  Academic Article
• Blood tests for the diagnosis of venous and arterial thrombosis  Academic Article
• Capillary Whole Blood Monitoring of Oral Anticoagulants in Children in Outpatient Clinics and the Home Setting  Academic Article
• Carrier detection strategy in haemophilia A: the benefits of combined DNA marker analysis and coagulation testing in sporadic haemophilic families  Academic Article
• Catalysis of Thrombin Inhibition Provides an Index for Estimating the Antithrombotic Potential of Glycosaminoglycans in Rabbits  Academic Article
• Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity  Academic Article
• Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes  Conference Paper
• Circulating heparin‐like anticoagulants: Case report and review of literature  Academic Article
• Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel  Academic Article
• Coagulation Assays  Academic Article
• Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure  Academic Article
• Combined administration of barbourin–albumin and hirudin–albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta  Academic Article
• Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist  Academic Article
• Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease  Academic Article
• Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis  Academic Article
• Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations  Academic Article
• Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models  Academic Article
• Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism.  Academic Article
• Congenital afibrinogenaemia.  Academic Article
• Critical Values in the Coagulation Laboratory Results of a Survey of the North American Specialized Coagulation Laboratory Association  Academic Article
• Dabigatran monitoring made simple?  Academic Article
• Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran  Academic Article
• Development of the human coagulation system in the full-term infant  Academic Article
• Developmental haemostasis  Academic Article
• Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation  Academic Article
• Diagnosis of thrombosis. Evaluation of 125I-fibrinogen scanning and blood tests.  Academic Article
• Diagnostic Assessment of Platelet Disorders: What Are the Challenges to Standardization?  Academic Article
• Diagnostic Evaluation of Platelet Disorders: The Past, the Present, and the Future  Academic Article
• Diagnostic approach to platelet function disorders  Academic Article
• Differential diagnoses for sepsis‐induced disseminated intravascular coagulation: communication from the SSC of the ISTH  Academic Article
• Direct Oral Anticoagulants  Academic Article
• Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa–based methods overestimate antithrombin activity in some patients?  Academic Article
• Do Coagulation Screening Tests Detect Increased Generation of Thrombin and Plasmin in Sick Newborn Infants?  Academic Article
• Dosage Regimens for Streptokinase Treatment: Evaluation of a Standard Dosage Schedule  Academic Article
• Dysfibrinogenaemia and liver cell growth.  Academic Article
• Dysfibrinogenemia in Obstructive Liver Disease  Academic Article
• EVALUATION OF SUBCUTANEOUS CALCIUM HEPARIN THERAPY IN THE TREATMENT OF THROMBO‐EMBOLIC DISEASE  Academic Article
• Effect of Streptokinase on Hemostasis  Academic Article
• Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.  Academic Article
• Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers  Academic Article
• Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure  Academic Article
• Effect of streptokinase therapy on experimental fibrin-rich arterial thrombi.  Academic Article
• Effectiveness of Anticoagulants  Academic Article
• Elevated Platelet-Associated IgG in the Thrombocytopenia of Septicemia  Academic Article
• Evaluation of the Coagulation Profile Among Oral and Vaginal Combined Hormonal Contraceptive Users Using Sonoclot Coagulation Analyzer  Academic Article
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.  Academic Article
• Exploring some intersections between pharmacokinetics, factor VIII measurement and human morphometrics - impact of recent advances in haemophilia study design on our understanding of optimal haemophilia treatment  Academic Article
• Fetal Effects of Coumadin Administered During Pregnancy  Academic Article
• Frequency and mechanism of neonatal thrombocytopenia  Academic Article
• General mechanisms of coagulation and targets of anticoagulants (Section I)  Academic Article
• Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation  Academic Article
• Global haemostasis and point of care testing  Academic Article
• Guidelines for clotting studies in cancer patients. For the Scientific and Standardization Committee of the Subcommittee on Haemostasis and Malignancy International Society of Thrombosis and Haemostasis.  Academic Article
• HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS  Academic Article
• Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review  Academic Article
• Hemostatic System Activation in Patients with Lupus Anticoagulant and Essential Thrombocythemia  Academic Article
• Heparin Therapy in Venous Thromboembolism  Academic Article
• Heparin clearance and ex vivo recovery in newborn piglets and adult pigs  Academic Article
• Heparin kinetics in venous thrombosis and pulmonary embolism.  Academic Article
• High prevalence of abnormal preoperative coagulation tests in patients with adolescent idiopathic scoliosis  Academic Article
• Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation  Academic Article
• Identification of hemostatic markers that define the pre‐DIC state: A multi‐center observational study  Academic Article
• Immune-mediated thrombocytopenia of malaria.  Academic Article
• Immunodepletion of human plasma factor VIII  Academic Article
• Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients  Academic Article
• Inactivation of thrombin by antithrombin III on a heparinized biomaterial  Academic Article
• Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082  Academic Article
• Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta  Academic Article
• Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys  Academic Article
• Internal Quality Control Practices in Coagulation Laboratories: recommendations based on a patterns-of-practice survey  Academic Article
• International Committee Communications  Academic Article
• Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice  Academic Article
• Laboratory Investigations for Bleeding Disorders  Academic Article
• Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis  Academic Article
• Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants  Academic Article
• Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity  Academic Article
• Laboratory measurement of the direct oral anticoagulants  Academic Article
• Laboratory testing for fibrinogen abnormalities  Academic Article
• Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels  Academic Article
• Lupus Anticoagulant Testing  Academic Article
• Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.  Academic Article
• Managing oral anticoagulant therapy.  Academic Article
• Measurement of the Activated Partial Thromboplastin Time from a Capillary (fingerstick) Sample of Whole Blood: A New Method for Monitoring Heparin Therapy  Academic Article
• Measuring Dabigatran Levels: What Tests Are Available and What Still Needs to Be Done?  Academic Article
• Mechanism of Action and Monitoring of Anticoagulants  Academic Article
• Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo  Academic Article
• Monitoring Unfractionated Heparin (UFH) therapy: Which Anti Factor Xa assay is appropriate?  Academic Article
• Monitoring and reversal of direct oral anticoagulants  Academic Article
• Monitoring the anticoagulant effect after a massive rivaroxaban overdose  Academic Article
• New Concepts in Coagulation  Academic Article
• New developments in laboratory diagnosis and monitoring  Academic Article
• Noninvasive Diagnosis of Deep Venous Thrombosis  Academic Article
• Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant  Academic Article
• Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange  Academic Article
• Performance of recalibrated ReFacto^®laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto^®(B-domain deleted recombinant factor VIII)  Academic Article
• Perioperative Evaluation of Bleeding Diathesis  Academic Article
• Placental Barrier to Coagulation Factors: Its Relevance to the Coagulation Defect at Birth and to Haemorrhage in the Newborn  Academic Article
• Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications  Academic Article
• Platelet factor 3 availability and the platelet release reaction  Article
• Point-of-Care Hemostatic Testing in Cardiac Surgery  Academic Article
• Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban  Academic Article
• Prevention of Venous Thromboembolism  Academic Article
• Proceedings: Efficacy and monitoring of heparin therapy in experimental venous thrombosis.  Academic Article
• Prolonged Prothrombin Time and Partial Thromboplastin Time in Disseminated Intravascular Coagulation not Due to Deficiency of Factors V and VIII  Academic Article
• Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency: reply to a rebuttal  Academic Article
• Präoperative Bewertung des Blutungs- und Thromboseembolierisikos  Academic Article
• Pseudothrombocytopenia Due to Platelet Aggregation and Degranulation in Blood Collected in EDTA  Academic Article
• RELEVANCE OF PREOPERATIVE AND POSTOPERATIVE BLOOD TESTS TO POSTOPERATIVE LEG-VEIN THROMBOSIS  Academic Article
• Real‐world variability in dabigatran levels in patients with atrial fibrillation  Academic Article
• Relation Between Bleeding Time and Platelet Connective Tissue Reaction After Aspirin  Academic Article
• Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis  Academic Article
• Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban  Academic Article
• Resolution of Experimental Pulmonary Emboli with Heparin and Streptokinase in Different Dosage Regimens  Academic Article
• Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism  Academic Article
• Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography  Academic Article
• Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis  Academic Article
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia  Academic Article
• Severe thrombophilia in a factor V‐deficient patient homozygous for the Ala2086Asp mutation (FV Besançon)  Academic Article
• Shortening of the Bleeding Time in Rabbits by Hydrocortisone Caused by Inhibition of Prostacyclin Generation by the Vessel Wall  Academic Article
• Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis  Academic Article
• Streptokinase in acute major pulmonary embolism.  Academic Article
• Studies on East African Snakes  Academic Article
• Studies on the coagulant enzyme from Agkistrodon rhodostoma venom. Isolation and some properties of the enzyme  Academic Article
• Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial  Academic Article
• The Activated Partial Thromboplastin Time in the Control of Heparin Treatment  Academic Article
• The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy  Academic Article
• The Influence of Age on in vitro Plasmin Generation in the Presence of Fibrin Monomer  Academic Article
• The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study  Academic Article
• The Value of Plasma Calibrants in Correcting Coagulometer Effects on International Normalized Ratios:An International Multicenter Study  Academic Article
• The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.  Academic Article
• The appended tail region of heparin cofactor II and additional reactive centre loop mutations combine to increase the reactivity and specificity of α1-proteinase inhibitor M358R for thrombin  Academic Article
• The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig  Academic Article
• The direct thrombin inhibitor hirudin  Academic Article
• The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization.  Academic Article
• The fraction of recombinant factor VIII:Ag unable to bind von Willebrand factor has no FVIII coagulant activity: studiesin vitro  Academic Article
• The influence of drugs upon the anticoagulant activity of heparin.  Academic Article
• The influence of heparin, NaCl and CaCl2 on the rate of the thrombin-antithrombin III reaction  Academic Article
• The multiple faces of the partial thromboplastin time APTT  Academic Article
• The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin  Academic Article
• The unique characteristics of COVID-19 coagulopathy  Academic Article
• The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease.  Academic Article
• Theoretical and Practical Aspects of Thrombolytic Therapy  Academic Article
• Thrombin Generation  Academic Article
• Thrombin activation rate constant: One-stage chromogenic assay for the extrinsic system  Academic Article
• Thrombin generation abnormalities in commonly encountered platelet function disorders  Academic Article
• Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation.  Academic Article
• Thrombin/Antithrombin III Complex Formation in the Neonatal Respiratory Distress Syndrome  Academic Article
• Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis  Academic Article
• Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin  Academic Article
• Thrombotic and Hemorrhagic Complications in Children With the Lupus Anticoagulant  Academic Article
• Thrombus stability explains the factor V Leiden paradox: a mouse model  Academic Article
• Transfusion-Induced Specific Anti–Factor XI Inhibitor in a Patient with Previously Unrecognized Factor XI Deficiency  Academic Article
• Treatment of Venous Thromboembolism  Academic Article
• Treatment of venous thromboembolic disease.  Academic Article
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels  Academic Article
• Urgent Need to Measure Effects of Direct Oral Anticoagulants  Academic Article
• VON WILLEBRAND'S DISEASE  Academic Article
• Vasoflux, a New Anticoagulant With a Novel Mechanism of Action  Academic Article
• Von Willebrand's Syndrome Presenting as an Acquired Bleeding Disorder in Association With a Monoclonal Gammopathy  Academic Article
• What is the effect of rivaroxaban on routine coagulation tests?  Academic Article
• [Population pharmacokinetics of two recombinant human coagulation factor Ⅷ preparations in patients with hemophilia A].  Academic Article
• von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis  Academic Article